UK SME offers a patent-protected “niche-in-a-dish” cell culture platform SENCE™ (Substrate-Enhanced Niche Culture Environment) enabling high-fidelity cell culture for advanced therapies and drug discovery.
A UK SME has developed SENCE™(Substrate-Enhanced Niche Culture Environment), a patent-protected cell culture platform that mimics native tissue niches. The company has experience with T cells, CNS cells, Chondrocytes, Cholangiocytes, iPSCs and more. They seek research cooperation, strategic commercial partners and investment agreements to accelerate product validation and scale-up.